Blockade of leukotriene B4 signaling pathway induces apoptosis and suppresses cell proliferation in colon cancer - PubMed (original) (raw)
doi: 10.1254/jphs.fp0060651. Epub 2007 Jan 13.
Affiliations
- PMID: 17220595
- DOI: 10.1254/jphs.fp0060651
Free article
Blockade of leukotriene B4 signaling pathway induces apoptosis and suppresses cell proliferation in colon cancer
Aya Ihara et al. J Pharmacol Sci. 2007 Jan.
Free article
Abstract
We investigated whether leukotriene B(4) (LTB(4)) and its signaling pathway play an important role in the progression of human colon cancer via a direct stimulation of cancer cell proliferation. Remarkable expression of LTB(4) receptor 1 (BLT1) in human colon cancer tissues was detected by immunohistochemistry, and Western blot analysis revealed the BLT1 expression in cultured human colon cancer cell lines, Caco2 and HT29. The 5-lipoxygenase inhibitor AA-861 and LTB(4)-receptor antagonist U75302 showed negative effects on survival and proliferation of both Caco2 and HT-29 cells. The inhibition of cell proliferation is due to the apoptosis because nuclear condensation and increased annexin V expression were observed in the cells treated with AA-861 and U75302. Knockdown of BLT1 by small interfering RNA caused the suppression of BLT1 protein, resulting in the inhibition of cancer cell proliferation. Blockade of BLT1 by the receptor antagonist significantly suppresses the LTB(4)-stimulated extracellular signal-regulated kinase (ERK) activation in colon cancer cells. These results indicate that the blockade of the LTB(4)-signaling pathway induces apoptosis via the inhibition of ERK activation in colon cancer cells. The LTB(4)-signaling pathway might be a new therapeutic target for colon cancer.
Similar articles
- Modulation of leukotriene B4 receptor-1 expression by dexamethasone: potential mechanism for enhanced neutrophil survival.
Stankova J, Turcotte S, Harris J, Rola-Pleszczynski M. Stankova J, et al. J Immunol. 2002 Apr 1;168(7):3570-6. doi: 10.4049/jimmunol.168.7.3570. J Immunol. 2002. PMID: 11907121 - Leukotriene B4 signaling through NF-kappaB-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia.
Bäck M, Bu DX, Bränström R, Sheikine Y, Yan ZQ, Hansson GK. Bäck M, et al. Proc Natl Acad Sci U S A. 2005 Nov 29;102(48):17501-6. doi: 10.1073/pnas.0505845102. Epub 2005 Nov 17. Proc Natl Acad Sci U S A. 2005. PMID: 16293697 Free PMC article. - The role of leukotriene B(4) in allergic diseases.
Ohnishi H, Miyahara N, Gelfand EW. Ohnishi H, et al. Allergol Int. 2008 Dec;57(4):291-8. doi: 10.2332/allergolint.08-RAI-0019. Epub 2008 Dec 1. Allergol Int. 2008. PMID: 18797182 Review. - Leukotriene B4 receptor antagonists as therapeutics for inflammatory disease: preclinical and clinical developments.
Hicks A, Monkarsh SP, Hoffman AF, Goodnow R Jr. Hicks A, et al. Expert Opin Investig Drugs. 2007 Dec;16(12):1909-20. doi: 10.1517/13543784.16.12.1909. Expert Opin Investig Drugs. 2007. PMID: 18042000 Review.
Cited by
- Activity of the leukotriene pathway in Barrett's metaplasia and oesophageal adenocarcinoma.
Shutt JD, Boger P, Neale JR, Patel P, Sampson AP. Shutt JD, et al. Inflamm Res. 2012 Dec;61(12):1379-84. doi: 10.1007/s00011-012-0539-2. Epub 2012 Aug 1. Inflamm Res. 2012. PMID: 22851204 - Eicosanoids and cancer.
Wang D, Dubois RN. Wang D, et al. Nat Rev Cancer. 2010 Mar;10(3):181-93. doi: 10.1038/nrc2809. Epub 2010 Feb 19. Nat Rev Cancer. 2010. PMID: 20168319 Free PMC article. Review. - Role of bacterial infection in the epigenetic regulation of Wnt antagonist WIF1 by PRC2 protein EZH2.
Roy BC, Subramaniam D, Ahmed I, Jala VR, Hester CM, Greiner KA, Haribabu B, Anant S, Umar S. Roy BC, et al. Oncogene. 2015 Aug 20;34(34):4519-30. doi: 10.1038/onc.2014.386. Epub 2014 Dec 8. Oncogene. 2015. PMID: 25486432 Free PMC article. - Lipidome in colorectal cancer.
Yan G, Li L, Zhu B, Li Y. Yan G, et al. Oncotarget. 2016 May 31;7(22):33429-39. doi: 10.18632/oncotarget.7960. Oncotarget. 2016. PMID: 26967051 Free PMC article. Review. - A novel positive feedback loop involving FASN/p-ERK1/2/5-LOX/LTB4/FASN sustains high growth of breast cancer cells.
Hu N, Li Y, Zhao Y, Wang Q, You JC, Zhang XD, Ye LH. Hu N, et al. Acta Pharmacol Sin. 2011 Jul;32(7):921-9. doi: 10.1038/aps.2011.40. Epub 2011 Jun 6. Acta Pharmacol Sin. 2011. PMID: 21643005 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous